FIELD: chemistry.
SUBSTANCE: present invention relates to compounds of formula (I), where R1-R8 such as defined herein, or pharmaceutically acceptable salts thereof, as inhibitors of ubiquitin-C-terminal hydrolase L1 (UCHL1).
EFFECT: present invention also relates to use of compounds for treating cancer, which is associated with UCHL1 activity and other conditions associated with UCHL1.
18 cl, 2 dwg, 15 tbl, 266 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUNDS | 2016 |
|
RU2734256C2 |
| COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
| NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
| BICYCLIC NITROGEN-CONTAINING COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS | 2015 |
|
RU2685230C2 |
| N-ACYL-N'-(PYRIDIN-2-YL)CARBAMIDES AND THEIR ANALOGUES EXHIBITING ANTICANCER AND ANTIPROLIFERATIVE ACTIVITY | 2014 |
|
RU2769607C2 |
| BICYCLIC NITROGEN-CONTAINING COMPOUNDS AS AGONISTS OF M1 MUSCARINIC RECEPTORS | 2019 |
|
RU2811601C1 |
| BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
| 3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2003 |
|
RU2355679C2 |
| PAN-GENOMIC INHIBITORS OF THE HEPATITIS C VIRUS PROTEIN NS5A, PHARMACEUTICAL COMPOSITIONS, INTERMEDIATES FOR THE SYNTHESIS OF INHIBITORS, AND METHODS FOR THEIR PREPARATION AND USE | 2016 |
|
RU2669919C1 |
